Responses to carboplatin in BRCA1/2-mutated breast cancer

被引：3
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(18)30407-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E337 / E337
页数：1
相关论文
共 50 条
  • [1] The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
    Miklikova, Svetlana
    Trnkova, Lenka
    Plava, Jana
    Bohac, Martin
    Kuniakova, Marcela
    Cihova, Marina
    CANCERS, 2021, 13 (03) : 1 - 17
  • [2] GENOMICS OF BRCA1/2-MUTATED BREAST CANCERS
    Jonkers, J.
    CELLULAR ONCOLOGY, 2010, 32 (03) : 162 - 162
  • [3] Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
    Tutt, Andrew
    Tovey, Holly
    Cheang, Maggie Chon U.
    Kernaghan, Sarah
    Kilburn, Lucy
    Gazinska, Patrycja
    Owen, Julie
    Abraham, Jacinta
    Barrett, Sophie
    Barrett-Lee, Peter
    Brown, Robert
    Chan, Stephen
    Dowsett, Mitchell
    Flanagan, James M.
    Fox, Lisa
    Grigoriadis, Anita
    Gutin, Alexander
    Harper-Wynne, Catherine
    Hatton, Matthew Q.
    Hoadley, Katherine A.
    Parikh, Jyoti
    Parker, Peter
    Perou, Charles M.
    Roylance, Rebecca
    Shah, Vandna
    Shaw, Adam
    Smith, Ian E.
    Timms, Kirsten M.
    Wardley, Andrew M.
    Wilson, Gregory
    Gillett, Cheryl
    Lanchbury, Jerry S.
    Ashworth, Alan
    Rahman, Nazneen
    Harries, Mark
    Ellis, Paul
    Pinder, Sarah E.
    Bliss, Judith M.
    NATURE MEDICINE, 2018, 24 (05) : 628 - +
  • [4] Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
    Andrew Tutt
    Holly Tovey
    Maggie Chon U. Cheang
    Sarah Kernaghan
    Lucy Kilburn
    Patrycja Gazinska
    Julie Owen
    Jacinta Abraham
    Sophie Barrett
    Peter Barrett-Lee
    Robert Brown
    Stephen Chan
    Mitchell Dowsett
    James M Flanagan
    Lisa Fox
    Anita Grigoriadis
    Alexander Gutin
    Catherine Harper-Wynne
    Matthew Q. Hatton
    Katherine A. Hoadley
    Jyoti Parikh
    Peter Parker
    Charles M. Perou
    Rebecca Roylance
    Vandna Shah
    Adam Shaw
    Ian E. Smith
    Kirsten M. Timms
    Andrew M. Wardley
    Gregory Wilson
    Cheryl Gillett
    Jerry S. Lanchbury
    Alan Ashworth
    Nazneen Rahman
    Mark Harries
    Paul Ellis
    Sarah E. Pinder
    Judith M. Bliss
    Nature Medicine, 2018, 24 : 628 - 637
  • [5] Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
    Kufel-Grabowska, Joanna
    Podolak, Amira
    Maliszewski, Daniel
    Bartoszkiewicz, Mikolaj
    Ramlau, Rodryg
    Lukaszuk, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [6] Molecular profiling comparison of BRCA1/2-mutated and BRCA1/2 non-mutated triple-negative breast cancer (TNBC)
    Arguello, D.
    Abbott, B.
    Reddy, S.
    Gatalica, Z.
    Obeid, E.
    Goldstein, L.
    CANCER RESEARCH, 2016, 76
  • [7] Secondary BRCA1/2 mutations are associated with platinum resistance in BRCA1/2-mutated ovarian carcinomas
    Norguist, B.
    Taniguchi, T.
    Wurz, K.
    Karlan, B.
    Villegas, E.
    Sakai, W.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 594 - 594
  • [8] Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
    Blum, Joanne L.
    Laird, A. Douglas
    Litton, Jennifer K.
    Rugo, Hope S.
    Ettl, Johannes
    Hurvitz, Sara A.
    Martin, Miguel
    Roche, Henri H.
    Lee, Kyung-Hun
    Goodwin, Annabel
    Chen, Ying
    Lanzalone, Silvana
    Chelliserry, Jijumon
    Czibere, Akos
    Hopkins, Julia F.
    Albacker, Lee A.
    Mina, Lida A.
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1383 - 1390
  • [9] BRCA1/2 reversion mutations as a mechanism of acquired drug resistance in BRCA1/2-mutated cancers
    Taniguchi, Toshiyasu
    CANCER SCIENCE, 2023, 114 : 260 - 260
  • [10] A phase Ib study of sapacitabine (sapa) and olaparib (ola) in patients (pts) with BRCA1/2-mutated (BRCA1/2m) metastatic breast cancer (MBC)
    Lynce, Filipa
    Graham, Noah
    Kochupurakkal, Bose S.
    Huy Nguyen
    Poorvu, Philip D.
    Attaya, Victoria
    Davis, Raechel
    Garg, Kavita
    Lim, Lee P.
    Li, Mark
    Paweletz, Cloud P.
    Tayob, Nabihah
    Shapiro, Geoffrey I.
    Tolaney, Sara M.
    CANCER RESEARCH, 2023, 83 (08)
12345